Switch to:
Synageva BioPharma Corp (NAS:GEVA)
Cash And Cash Equivalents
$70.45 Mil (As of Jun. 2014)

Synageva BioPharma Corp's quarterly cash and cash equivalents increased from Dec. 2013 ($62.14 Mil) to Mar. 2014 ($152.33 Mil) but then declined from Mar. 2014 ($152.33 Mil) to Jun. 2014 ($70.45 Mil).

Synageva BioPharma Corp's annual cash and cash equivalents declined from Dec. 2011 ($60.23 Mil) to Dec. 2012 ($23.88 Mil) but then increased from Dec. 2012 ($23.88 Mil) to Dec. 2013 ($62.14 Mil).


Definition

Cash and cash equivalents on banks book.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Synageva BioPharma Corp Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
BS_CashAndCashEquivalents 28.1023.5630.0532.7014.3947.4214.7260.2323.8862.14

Synageva BioPharma Corp Quarterly Data

Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14
BS_CashAndCashEquivalents 138.92138.86233.4123.8853.7647.76216.8762.14152.3370.45
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK